Home Our Services Research Doing research with us

Doing research with us

Featured: Our Year in Review View Icon Oncology Group's Annual Research Report to learn more about our research portfolio.

Supporting research capability

Research across Icon Oncology Group is conducted through the Icon Cancer Centre (ICC) global network.

ICC participates in a wide variety of clinical trials and research projects ranging from global, multi-centre, commercially-sponsored clinical trials of experimental agents, to studies developed by employees, doctors and visiting medical officers (VMOs) for our patients.

This research aims to better understand, treat, or alleviate the diagnosis, symptoms or concerns of patients with cancer and blood disorders.

Research across the network facilitates:

Direct access to clinical trials for patients as close to home as possible

Trial management and delivery with Australia’s largest private provider of cancer clinical trials

Coverage across Australia, New Zealand and Singapore cancer centres

Specialised facilities with cutting-edge technologies

Passionate clinicians and a commitment to an innovative research-oriented environment.

Ethics, quality and governance

As part of Icon Oncology Group, the ICC research network provides clinical trial sponsors with a comprehensive site management service, which allows access to multiple sites under a single ethics submission and governance structure including one contract, one budget and one indemnity. This increases efficiencies and improves study start-up timelines.

ICC is committed to the highest research standards and Icon Oncology Group’s dedicated Quality team ensures compliance with Good Clinical Practice (GCP), the TGA Clinical Trials Handbook, the NHMRC National Statement and all applicable national and international guidelines.

The Group’s Quality Management System, standard operating procedures (SOPs) and policies are implemented uniformly across each Icon Cancer Centre, ensuring standardised management of clinical trials. Icon provides ongoing comprehensive training and education to the research teams to ensure they continue to deliver consistently high standards.

Independent validation of research excellence

As part of Icon Oncology Group, ICC is proud to hold GCSA Certification, the Global Quality Standard for Clinical Research Sites, and Gold-level Workforce Process Quality Certification (WPQC). Awarded by the International Accrediting Organisation for Clinical Research (IAOCR), the award builds on the Group’s milestone in 2024 when it became the first Australian clinical trial site network to achieve both certifications. In 2026 we are proud to successfully renew our GCSA Certification and progress from WPQC Silver to Gold.  

Together, these internationally recognised certifications provide independent assurance of our commitment to quality, governance, operational excellence, workforce capability and participant-centred delivery of clinical trials and research.

They reinforce confidence that clinical trials and research conducted across the ICC network is delivered to globally recognised standards and supported by a culture of continuous improvement.  

Learn more about our quality certifications and research excellence here.

Working with us

Icon Oncology Group is proud to export Australian clinical expertise, alongside in-depth local knowledge and investment in innovative new technologies, to continue to deliver the best care possible, to as many people as possible, as close to home as possible across the globe.

Making a difference in reducing the global cancer burden is a collaborative effort and we are committed to continuing to extend our research partnerships and activities by partnering with new organisations who share common values in order to play a leading role in changing the face of cancer care.

We offer a number of benefits including:

Centralised and timely data management and query resolution services
Advice for support of investigator-driven research opportunities

Coordination of new study protocol review by the investigator group
Completion of feasibility assessments for new study protocols
Evaluation of research proposals at Research Committees
Collection and maintenance of documentation
Facilitation of ethical and research governance approvals
Research budget assessment and single contract negotiation
Entry and oversight of the protocol on the Clinical Trial Management System
Financial management and revenue recovery for the protocol

If you would like to work with us to deliver national and international clinical research trials, please email [email protected]

Investigator Initiated Trials (IITs) at Icon Cancer Centre

IITs being conducted across the ICC research network are sponsored by Icon Cancer Foundation, a not-for-profit organisation whose mission is to promote, initiate and support clinical trials and research, striving towards a brighter future for cancer patients and communities. These unique investigator led trials, are in all oncology disciplines including medical oncology, haematology, radiation oncology, as well as pharmacy, nursing and medical physicist led trials. Icon Cancer Foundation are supported by the research team to develop, support and manage IITs across the global network.

Learn more about Icon Cancer Foundation

Industry partnerships and collaborations

ICC is proud to work with over 200 collaborators including Contract Research Organisations (CROs), commercial and non-commercial organisations (including the pharmaceutical industry, hospitals, and universities), industry vendors and service providers.

Clinical Oncology Society of Australia (COSA)

Our research team collaborated with COSA for their Annual Scientific Meeting through facilitation of the Pre- Conference Workshop ‘Tele-trials, the new norm?’. In line with the virtual theme the workshop was also made available via Icon Oncology Group’s digital platforms to participants around the world. This split presentation model provided opportunities to a wide variety of industry partners and participants to gain the most out of these resources in a platform that works for them.

The University of Queensland (UQ) and Queensland University of Technology (QUT)

ICC’s Research teams continue to collaborate with leading Queensland universities, UQ and QUT to provide work-integrated learning placements to undergraduate students interested in pursuing a career in research.

Varian Medical Systems

Icon Oncology Group is proud to have a global partnership with radiation oncology industry leaders, Varian Medical Systems (Varian), the cancer–care business of Siemens Healthineers. This partnership has extended to research with the intention to establish an improved process for identification, prioritisation and support of Icon Investigator-Initiated projects that align with Varian’s values and vision to further advance radiation therapy techniques.

Wesley Medical Research

ICC and Wesley Medical Research (in Queensland) have a longstanding relationship and are currently collaborating on a retrospective analysis of survival outcomes following autologous haematopoietic stem cell transplantation (ASCT) in the private sector. ICC performs the highest number of ASCT in Australasia with most transplants performed at The Wesley Hospital. This analysis will audit survival outcomes post-ASCT performed at ICC, including the development of a comprehensive database to ensure the high quality of clinical outcomes.

About us

Icon Oncology Group is Australia’s largest dedicated cancer care provider and has expanded globally into New Zealand, Asia and the United Kingdom.

Our people

People from across Icon Oncology Group share their stories of success, career progression and being iconic.

A career with us

At Icon Oncology Group, you’ll help change lives, every single day. In return for your passion, dedication and agility, we offer a workplace where you can.

Updates

Read the latest news and updates across Icon Oncology Group.